News

Hospiten Roca presents its Weight Loss Support Unit: a new approach based on body composition

Written by Hospiten | May 4, 2026 11:12:53 AM

Hospiten Roca launches its Weight Loss Support Unit, a new service that is committed to an innovative and personalized approach to the treatment of overweight and obesity. The unit is headed by Dr. Carlos Blanco-Soler, head of the unit, and represents a paradigm shift by going beyond weight and body mass index (BMI), incorporating detailed analysis of body composition and metabolic function as the basis for treatment.

"BMI alone does not tell us how fat behaves in the body or the actual health risk. We need to go further and analyze body composition to design truly effective treatments tailored to each patient," explains Dr. Blanco-Soler.

The program begins with an initial medical assessment together with the nutritionist, where a complete morphofunctional evaluation is carried out and personalized objectives are established. Subsequently, the patient receives nutritional follow-up for three months, with adapted guidelines and evolution control. At the end of this period, a new medical check-up is performed to assess results and adjust the treatment if necessary.

"This follow-up allows us to accompany the patient on an ongoing basis, ensuring that the changes are sustainable and that metabolic health improves in a real way," says the head of the unit.

The unit introduces morphofunctional assessment, a comprehensive analysis that provides insight into how fat is distributed in the body, the quality of muscle mass and the patient's metabolic status. This assessment includes:

  • Electrical bioimpedance (BIA), to estimate fat mass and lean mass.
  • Nutritional and muscular ultrasound, to differentiate visceral and subcutaneous fat.
  • Dynamometry, to measure muscle strength and prevent sarcopenic obesity.
  • Specific tests to detect inflammation, insulin resistance and hormonal alterations.

"Only 69% of cardiovascular events are explained by classical factors. With this assessment, we can identify hidden risks and act before complications appear," adds Dr. Blanco-Soler.

With this information, the team designs individualized plans that combine nutrition, exercise and, when necessary, innovative pharmacological treatments such as GLP-1 analogs, which have demonstrated efficacy in weight loss and improvement of the cardiometabolic profile.

"Our goal is to accompany the patient with a medical, scientific and humane approach. There are no miracle solutions, but there are safe and effective treatments that can change lives," stresses the head of the unit.

This article is an English translation generated with AI from the original Spanish content. While we review content for clarity, the information is provided for general informational purposes only and should not be considered medical advice. Always consult a qualified healthcare professional for diagnosis or treatment.